Search

EU: Call to end disparity in access to innovative medicines

New approaches to drug regulation and reimbursement are needed to improve access to innovation, advance patients’ rights and ensure patients are involved in policy making and regulatory processes, according to speakers at the 11th European Patients’ Rights day, held in Brussels earlier this month